Chintan S Desai1, Hongyan Ning2, Kiang Liu2, Jared P Reis3, Samuel S Gidding4, Anderson Armstrong1, Joao A C Lima1, Donald M Lloyd-Jones5. 1. Division of Cardiology, Johns Hopkins Hospital, Baltimore, Maryland. 2. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 3. National Heart, Lung, and Blood Institute, Bethesda, Maryland. 4. Thomas Jefferson Medical Center, Philadelphia, Pennsylvania. 5. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: dlj@northwestern.edu.
Abstract
BACKGROUND: The aim of this study was to determine the association between cardiovascular health (CVH) in young adulthood and left ventricular (LV) structure and function later in life. METHODS: Participants from the Coronary Artery Risk Development in Young Adults study, which recruited black and white participants aged 18 to 30 years at baseline, were included; echocardiography was performed at year 25. CVH at year 0 was defined on the basis of blood pressure, total cholesterol, fasting glucose, body mass index, smoking status, diet, and physical activity. Two, 1, or 0 points were assigned to each component for ideal, intermediate, and poor levels of each component. Participants were stratified into CVH groups on the basis of point score: ≤ 8 (poor), 9 to 11 (intermediate), and 12 to 14 (ideal). RESULTS: The distribution of CVH at year 0 was as follows: poor, n = 264 (9%); intermediate, n = 1,315 (47%); and ideal, n = 1,224 (44%). Individuals with ideal and intermediate CVH at year 0 had significantly lower LV end-diastolic volume and lower LV mass index at year 25. In participants with ideal and intermediate CVH, the multivariate-adjusted odds ratios for diastolic dysfunction at year 25 was 0.52 (95% CI, 0.37-0.73) and 0.63 (95% CI, 0.46-0.83), respectively, compared with participants with poor CVH. Participants with ideal and intermediate CVH had significantly lower odds for LV hypertrophy; the LV mass index was 5.3 to 8.7 g/m(2.7) lower (P < .001 for both) than in participants with poor CVH. CONCLUSION: Greater levels of CVH in young adulthood are associated with lower LV mass and lower risk for diastolic dysfunction 25 years later.
BACKGROUND: The aim of this study was to determine the association between cardiovascular health (CVH) in young adulthood and left ventricular (LV) structure and function later in life. METHODS:Participants from the Coronary Artery Risk Development in Young Adults study, which recruited black and white participants aged 18 to 30 years at baseline, were included; echocardiography was performed at year 25. CVH at year 0 was defined on the basis of blood pressure, total cholesterol, fasting glucose, body mass index, smoking status, diet, and physical activity. Two, 1, or 0 points were assigned to each component for ideal, intermediate, and poor levels of each component. Participants were stratified into CVH groups on the basis of point score: ≤ 8 (poor), 9 to 11 (intermediate), and 12 to 14 (ideal). RESULTS: The distribution of CVH at year 0 was as follows: poor, n = 264 (9%); intermediate, n = 1,315 (47%); and ideal, n = 1,224 (44%). Individuals with ideal and intermediate CVH at year 0 had significantly lower LV end-diastolic volume and lower LV mass index at year 25. In participants with ideal and intermediate CVH, the multivariate-adjusted odds ratios for diastolic dysfunction at year 25 was 0.52 (95% CI, 0.37-0.73) and 0.63 (95% CI, 0.46-0.83), respectively, compared with participants with poor CVH. Participants with ideal and intermediate CVH had significantly lower odds for LV hypertrophy; the LV mass index was 5.3 to 8.7 g/m(2.7) lower (P < .001 for both) than in participants with poor CVH. CONCLUSION: Greater levels of CVH in young adulthood are associated with lower LV mass and lower risk for diastolic dysfunction 25 years later.
Authors: Joshua D Bundy; Hongyan Ning; Victor W Zhong; Amanda E Paluch; Donald M Lloyd-Jones; John T Wilkins; Norrina B Allen Journal: Circ Cardiovasc Qual Outcomes Date: 2020-06-30
Authors: Lifang Hou; Donald Lloyd-Jones; Brian T Joyce; Tao Gao; Yinan Zheng; Jiantao Ma; Shih-Jen Hwang; Lei Liu; Drew Nannini; Steve Horvath; Ake T Lu; Norrina Bai Allen; David R Jacobs; Myron Gross; Amy Krefman; Hongyan Ning; Kiang Liu; Cora E Lewis; Pamela J Schreiner; Stephen Sidney; James M Shikany; Daniel Levy; Philip Greenland Journal: Circ Res Date: 2021-08-25 Impact factor: 23.213
Authors: Michael P Bancks; Mercedes R Carnethon; Lisa S Chow; Samuel S Gidding; David R Jacobs; Satoru Kishi; Joao Lima; Donald Lloyd-Jones; Jared P Reis; Pamela J Schreiner; Rachel Zmora; Norrina B Allen Journal: J Diabetes Complications Date: 2019-02-06 Impact factor: 3.219
Authors: Amanda M Perak; Sadiya S Khan; Laura A Colangelo; Samuel S Gidding; Anderson C Armstrong; Cora E Lewis; Jared P Reis; Pamela J Schreiner; Stephen Sidney; Joao A C Lima; Donald M Lloyd-Jones Journal: J Am Soc Echocardiogr Date: 2020-11-17 Impact factor: 5.251
Authors: Donald M Lloyd-Jones; Cora E Lewis; Pamela J Schreiner; James M Shikany; Stephen Sidney; Jared P Reis Journal: J Am Coll Cardiol Date: 2021-07-20 Impact factor: 27.203